Letson Investment Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-20,000
Closed -$485K 101
2025
Q2
$485K Hold
20,000
0.19% 64
2025
Q1
$507K Sell
20,000
-151
-0.7% -$3.95K 0.2% 59
2024
Q4
$535K Sell
20,151
-48
-0.2% -$1.3K 0.22% 60
2024
Q3
$585K Sell
20,199
-1,913
-9% -$55.8K 0.23% 60
2024
Q2
$619K Hold
22,112
0.27% 59
2024
Q1
$614K Sell
22,112
-1,239
-5% -$34.4K 0.26% 61
2023
Q4
$672K Buy
+23,351
New +$706K 0.31% 57

Other funds holding PFE

Letson Investment Management's PFE Position: Q3 2025 in Review

Letson Investment Management sold out of Pfizer (PFE) in Q3 2025, closing a stake of 20,000 shares — an estimated $485K sold.

Letson Investment Management first reported a position in PFE in Q4 2023 and held it in 7 quarters. The position peaked at $672K in Q4 2023. 2,812 funds tracked by Wall St. Rank hold PFE as of Q3 2025.

  • Letson Investment Management reported no remaining Pfizer position as of Q3 2025 after selling out during the quarter.
  • Letson Investment Management sold 20,000 Pfizer shares in Q3 2025, an estimated $485K.
  • Letson Investment Management first reported a position in Pfizer in Q4 2023 and held it in 7 quarters.
  • Letson Investment Management's Pfizer position peaked at $672K in Q4 2023.
  • 2,812 funds tracked by Wall St. Rank held Pfizer as of Q3 2025.

Based on Letson Investment Management's 13F filing for Q3 2025, filed 22 Oct 2025.